After going through research and clinical trials, Treatibles is the first line of organic, full sepctrum hemp oil with naturally-occuring CBD products available in the country. The clinical trials were conducted by The Society of Animal CBD Research, led by Dr. Chie Mogi (Veterinary Medicine), associate professor, faculty of animal nursing at Yamazaki University of Animal Nursing. The society was established in November 2019 for veterinarians and researchers to promote CBD research with small animals in Japan. Case studies continue to be conducted in cooperation with researchers of cannabinoids and veterinarians who are specifically interested in this field. Treatibles was hand-selected by Takakura New Industries, Inc., a leader in developing and marketing natural pet products in Japan.
"Treatibles is the only hemp-derived CBD product for pets currently available in Japan, in which clinical trials and research with pets were conducted in collaboration with universities and veterinarians prior to the product launch," said Julianna Carella, founder and CEO of Treatibles. "Getting the Treatibles products approved for distribution in Japan meant finding great partners that could dedicate the necessary resources to this effort. We are thrilled to be working with such a respected distributor as Takakura New Industries."